<DOC>
	<DOCNO>NCT01762501</DOCNO>
	<brief_summary>To determine efficacy Azilsartan 20 mg versus Amlodipine 5 mg oral administration per day 8 week patient grade I grade II essential hypertension .</brief_summary>
	<brief_title>Azilsartan Circadian Sleep Pressure</brief_title>
	<detailed_description>Treatment &lt; Run-in period &gt; Use antihypertensive , include azilsartan amlodipine , prohibit run-in period . &lt; Treatment period &gt; Subjects consider eligible participation study base result eligibility assessment run-in period randomize azilsartan 20 mg amlodipine 5 mg group ratio 1:1 accord follow stratification factor ; type awake-sleep blood pressure variation determine base data ABPM start run-in , complication status ( chronic kidney disease [ CKD ] , type 2 diabetes ) , age , sex . Subjects start treatment either antihypertensive examination start treatment ( Week 0 ) visit study site every 2 week , 5 visit total , end treatment ( Week 8 ) . Subjects orally take azilsartan 20 mg amlodipine 5 mg , accord group allocation , daily breakfast morning .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Amlodipine</mesh_term>
	<criteria>Grade I II essential hypertension The sit systolic blood pressure term 140179 mmHg , sit diastolic blood pressure term 90109 mmHg two time point begin observation period begin treatment period ( Week0 ) 20 year old old time inform consent Able give write informed consent participate research Therapeutic category observation period : Ambulatory Secondary hypertension , grade III hypertension ( sit systolic blood pressure great equal 180 mmHg sit diastolic blood pressure great equal 110 mmHg ) , malignant hypertension More 2 kind antihypertensive agent treatment hypertension History take follow medicine within 2 week start observation period . When subject take follow medicine time inform consent include , stop take medicine determine period inform consent . I. Antihypertensive agent II . Antianginal agent III . Antiarrhythmic agent ( except single time use lidocaine hydrochloride formulation anesthesia ) IV . Digitalis product Less 130 mmHg mean 24hour systolic blood pressure le 80 mmHg mean 24hour diastolic blood pressure start observation period . History follow circulatoryrelated disease symptom within 24 week start observation period . I. Cardiac disease : Myocardial infarction , coronary artery revascularization II . Cerebrovasculardisease : cerebral infarction , cerebral hemorrhage , transient ischemic attack III . Progressive hypertensive retinopathy : hemorrhage , exudation , papilledema History complication follow circulatoryrelated disease ; Valvular stenosis , atrial fibrillation , pharmacotherapyrequired angina , congestion heart failure , cardiac arrhythmia , arteriosclerosis obliterans symptoms intermittent claudication et al Day / night reversal History hypersensitivity allergy Azilsartan , Amlodipine , related drug Participant clinical research Pregnant , possible pregnant , lactate woman Malcontrol blood pressure inform consent take antihypertensive agent Any investigator researcher consider unsuitable</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>Hypertension</keyword>
</DOC>